Celldex Therapeutics
CLDX
#4537
Rank
โ‚ฌ1.71 B
Marketcap
25,86ย โ‚ฌ
Share price
3.05%
Change (1 day)
-1.61%
Change (1 year)

EPS for Celldex Therapeutics (CLDX)

EPS in 2023 (TTM): -2,27ย โ‚ฌ

According to Celldex Therapeutics's latest financial reports the company's current EPS (TTM) is -2,30ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -2,29ย โ‚ฌ a decrease over its 2021 EPS that were of -1,57ย โ‚ฌ.

EPS history for Celldex Therapeutics from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,27ย โ‚ฌ-0.84%
2022-2,29ย โ‚ฌ45.73%
2021-1,57ย โ‚ฌ-23.36%
2020-2,05ย โ‚ฌ-41.05%
2019-3,47ย โ‚ฌ-76.95%
2018-15,08ย โ‚ฌ45.03%
2017-10,40ย โ‚ฌ-42.54%
2016-18,09ย โ‚ฌ-3.82%
2015-18,81ย โ‚ฌ-0.76%
2014-18,95ย โ‚ฌ29.41%
2013-14,65ย โ‚ฌ0%
2012-14,65ย โ‚ฌ-9.73%
2011-16,22ย โ‚ฌ1312.5%
2010-1,15ย โ‚ฌ-95.79%
2009-27,26ย โ‚ฌ-49.64%
2008-54,13ย โ‚ฌ-82.64%
2007-311,86ย โ‚ฌ-44.98%
2006-566,85ย โ‚ฌ1270.83%
2005-41,35ย โ‚ฌ33.33%
2004-31,01ย โ‚ฌ-10%
2003-34,46ย โ‚ฌ-16.67%
2002-41,35ย โ‚ฌ-38.46%
2001-67,20ย โ‚ฌ-4.88%
2000-70,64ย โ‚ฌ-79.16%
1999-339,01ย โ‚ฌ-87.2%
1998-2.648ย โ‚ฌ206.39%
1997-864,09ย โ‚ฌ13.02%
1996-764,58ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-3,84ย โ‚ฌ 67.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,81ย โ‚ฌ-64.58%๐Ÿ‡บ๐Ÿ‡ธ USA
-11,56ย โ‚ฌ 403.33%๐Ÿ‡บ๐Ÿ‡ธ USA
13,54ย โ‚ฌ-689.58%๐Ÿ‡บ๐Ÿ‡ธ USA
1,78ย โ‚ฌ-177.50%๐Ÿ‡บ๐Ÿ‡ธ USA
3,35ย โ‚ฌ-245.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
-0,55ย โ‚ฌ-76.25%๐Ÿ‡บ๐Ÿ‡ธ USA